Institutional Career Development Core

机构职业发展核心（KL 2）的目标，当地称为约翰霍普金斯临床 研究学者计划，是发展和支持青年教师从约翰霍普金斯大学 和马里兰州大学巴尔的摩医学院、公共卫生学院、护理学院、药学院和工程学院 成为独立，道德，创新和变革性的临床和转化研究领导者。 学者获得广泛的知识转化研究途径，获得技能，以适应和提高 翻译研究模式，并能够在多学科团队中创造性地合作 环境，以推进和产生新的知识，以改善人类健康。基本纲领 内容包括高级教学课程、开展研究的实践培训、完成赠款 写作课程，接触创新的研究方法和技术，“动手”指导研究 经验和全面的职业发展活动，旨在创造一个环境， 鼓励跨学科的方法，并最大限度地提高成功的职业生涯在临床和 翻译研究所有学者将学习生物设计方法，“大数据”方法， 学术创业和健康差距。KL 2计划将支持9名初级教师学者 为期2年，随后保证提名部门提供额外一年的支持。新 该计划将合并约翰霍普金斯医学院，公共卫生，护理， 和工程，以及约翰霍普金斯卫生系统的专业知识，我们的新的卢旺达问题国际法庭的合作伙伴， 马里兰州大学医学院、护理学院、药学院、牙科学院、社会工作学院和法学院，以及 马里兰州大学医学中心。这些方案的整合将导致以受训者为中心， 多学科学习，提高初级教师获得高级培训，特别是那些来自 没有经过正式培训的临床研究人员的历史的学科;最大限度地为最广泛的可能性 学科之间的交叉施肥;创造核心资源，促进初级教师的一流研究， 否则可能缺乏资源来聘请足够的分析，统计和技术支持;并提高 该方法对机构文化的影响。KL 2计划的预期成果是开发 并培养下一代研究人员，他们具备临床和 翻译研究，谁将成功地过渡到职业发展计划，如K 08或K23 指导临床医生科学家奖，并最终在临床和转化研究的独立职业生涯。

The objective of the Institutional Career Development Core (KL2), known locally as the Johns Hopkins Clinical Research Scholars Program, is to develop and support junior faculty from within the Johns Hopkins University and University of Maryland Baltimore Schools of Medicine, Public Health, Nursing, Pharmacy, and Engineering to become independent, ethical, innovative, and transformative clinical and translational research leaders. Scholars gain broad knowledge of the translational research pathway, acquire the skills to adapt and enhance translational research models, and are able to work creatively and collaboratively within multidisciplinary team environments to advance and generate new knowledge to improve human health. Fundamental program elements include advanced didactic coursework, practical training in conducting research, completion of a grant writing course, exposure to innovative research approaches and technology, “hands on” mentored research experience, and comprehensive career development activities designed to create an environment that encourages an interdisciplinary approach and maximizes the probability of successful careers in clinical and translational research. All Scholars will learn the basics about biodesign methods, “big data” approaches, academic entrepreneurship, and health disparities. The KL2 program will support nine junior faculty Scholars for 2 years, followed by an assurance of an additional year of support by the nominating divisions. The new program will merge the existing strengths within the Johns Hopkins Schools of Medicine, Public Health, Nursing, and Engineering, as well as the Johns Hopkins Health System with the expertise at our new ICTR partner at the University of Maryland Schools of Medicine, Nursing, Pharmacy, Dentistry, Social Work, and Law, as well as the University of Maryland Medical Center. Integration of these programs will lead to trainee-centered, multidisciplinary learning and enhance junior faculty access to advanced training, especially those from disciplines without a history of formally trained clinical researchers; maximize possibilities for the widest possible cross-fertilization among disciplines; create core resources that facilitate top-notch research by junior faculty who may otherwise lack the resources to hire adequate analytic, statistical, and technical support; and heighten the impact of the approach on the culture of the institution. The intended outcome of the KL2 program is to develop and train the next generation of researchers, who are equipped with a foundation of skills in clinical and translational research, who will successfully transition to career development programs, e.g. K08 or K23 mentored clinician scientist awards, and ultimately to an independent career in clinical and translational research.